These results argue that surgeon utilization of bracketed localization may be beneficial in these clinical scenarios. While these characteristics are typically associated with higher rates of positive margins, our cohort's rate of additional surgery was comparable to the national average for all BCS operations. This descriptive study shows that bracketed localization was most often employed for patients with large lesion spans, multifocality, and a DCIS or invasive lobular component. The LOCalizer wire-free guidance system is designed to mark and guide to non-palpable breast lesions using a miniature radiofrequency identification (RFID). Negative margins with BCS were achieved in 96% of cases, including those with successful re-excision. Invasive lobular carcinoma had the highest additional surgery rate at 23%. Additional surgery was performed in 17% of patients. Negative margins were achieved in 82% of patients on the first excision. Ductal carcinoma in situ (DCIS) was a histological component in 64% of core needle biopsies and 76% of surgical specimens. For more information or to make an appointment, please call 31. With an estimated 230,480 new cases in the year 2011, and 39,520 of them fatal, breast cancer remains the most common malignancy and the second leading cause of cancer-related deaths among women in the U.S. Multifocal lesions represented 45% of cases. Imaging showed an average lesion span of 5.0-cm. One hundred and thirteen cases were analyzed. Lesion characteristics were recorded including lesion span, number of lesions, histology type on core needle biopsy and surgical specimen, margin status, and need for additional surgery. Based on our experience, we aim to provide criteria that should prompt surgeons to consider bracketing.Ī single-institution retrospective chart review was performed on patients who underwent bracketed localization for BCS between 20. To date, there are no guidelines for when bracketed localization should be used in clinical practice. Hologic is an exclusive distributor and licensee of the LOCalizer product and trademark LOCalizer is manufactured by Health Beacons, Inc. Bracketed localization is a technique used to help localize lesions for breast-conserving surgery (BCS). Surgical Implant & Targeted Therapy are breast conserving surgery alternatives to whole breast radiation and mastectomy.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |